** Jefferies raises price target on U.S.-based agrichemicals company Corteva CTVA.N to $92 from $80; maintains "buy" rating
** New PT is 27.5% upside to stock's last close
** Brokerage says Corteva's leverage to increasing global acreage is a contrast to the concerns petrochemicals face over competitor supply additions
** It expects Corteva's competitive gap with Bayer will likely narrow this cycle, as Genetically Modified Organisms $(GMO)$ monopoly positions are harder to secure
** Brokerage notes that CTVA benefits from rising fertilizer prices and the end of destocking in crop chemicals
** 18 out 25 brokerages rate the stock "buy" or higher, 7 "hold"; median PT is $72.55 - data compiled by LSEG
** As of last close, CTVA up 25% YTD
(Reporting by Sumit Saha in Bengaluru)
((Sumit.Saha@thomsonreuters.com;))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.